Abdominal Wall Mass
An abdominal wall mass is a lump or swelling arising within the layers of the abdominal wall itself—the skin, fat, muscle, and fascia that form the front and sides of the abdomen—rather than from an organ inside the abdominal cavity. The great majority are benign, with lipomas, hernias, hematomas, and cysts accounting for most cases. A smaller proportion represent tumors requiring specific treatment, including desmoid tumors, sarcomas, and metastatic deposits. Because the range of possible causes is wide and the distinctions often cannot be made by examination alone, imaging plays a central role: it establishes whether the lump lies within the wall or beneath it, characterizes the tissue involved, and determines whether biopsy or further evaluation is needed.
What is it?
The abdominal wall is a layered structure: skin, subcutaneous fat, several sheets of muscle with their investing fascia, and a thin layer of preperitoneal fat and peritoneum on the inner surface. A mass can arise from any of these layers, and the layer of origin is often the most informative clue about what the mass is.
Abdominal wall mass is a descriptive term rather than a diagnosis. It is what a patient notices, a clinician palpates, or a radiologist reports before the cause is established. The task is therefore one of characterization: determining where the mass sits, what tissue it is made of, and whether it belongs to the large benign majority or the small group requiring specific treatment.
The first and most useful distinction is whether the mass lies within the abdominal wall or inside the abdominal cavity. A simple bedside maneuver helps: the patient lies flat and lifts the head and shoulders, tensing the abdominal muscles. A mass within the wall remains palpable or becomes more prominent, while a mass inside the abdomen becomes harder to feel as the tensed muscle covers it. This is sometimes called the Carnett or Fothergill sign depending on the specific application, and while not infallible, it usefully directs the workup.
The benign causes account for most abdominal wall masses.
Lipomas are benign tumors of fat and are among the most common soft tissue lesions anywhere in the body. They are typically soft, mobile, slow-growing, and painless, most often sitting in the subcutaneous layer. Most require no treatment. Deeper lipomas, those larger than about 5 cm, and those that are painful or growing warrant imaging, because a well-differentiated liposarcoma can closely resemble a lipoma and is distinguished by imaging features such as thickened septa and nodular components.
Epidermoid and sebaceous cysts arise in the skin and subcutaneous tissue and are usually superficial, mobile, and sometimes with a visible central punctum. They can become inflamed or infected.
Hernias are a frequent explanation for what a patient perceives as a lump. A hernia is distinguished by its tendency to change size with position and straining and by reducibility, though an incarcerated hernia or a hernia containing only fat may feel like a fixed solid mass. Spigelian hernias deserve particular mention here because they pass between muscle layers and may produce a mass or pain without an obvious surface bulge.
Rectus sheath hematoma results from bleeding within the rectus abdominis muscle sheath, usually from tearing of the inferior epigastric vessels or the muscle itself. It typically presents as sudden abdominal pain with a palpable, tender mass, often after coughing, straining, vigorous exercise, or minor trauma. Anticoagulant therapy is the single most important risk factor, and the condition is seen more often in older patients, in women, and during periods of severe cough. Bruising in the flank or lower abdomen may appear over subsequent days. It can be mistaken for an acute intra-abdominal condition, and imaging readily makes the distinction.
Post-surgical changes are common and frequently benign. Scar tissue, suture granulomas, seromas, and fat necrosis all produce palpable lumps near incisions. Mesh from prior hernia repair can be palpable, and can develop surrounding seroma or, uncommonly, infection.
Abdominal wall endometriosis deserves emphasis because it is frequently missed and the delay to diagnosis is often measured in years. Endometrial tissue becomes implanted in a surgical scar—most often a cesarean section scar, less often a laparoscopic port site or episiotomy scar—and responds to hormonal cycling. The classic presentation is a firm, tender mass at or near the scar with pain and swelling that worsen around menstruation, though the cyclical pattern is absent in a meaningful proportion of cases. It is commonly misdiagnosed as a hernia, lipoma, granuloma, or abscess. Imaging suggests the diagnosis, and wide excision is generally curative.
Infectious and inflammatory causes include abscess, which may arise from skin infection, a post-surgical collection, or extension from an intra-abdominal source such as Crohn’s disease or a perforated viscus. An abscess tracking from inside the abdomen through the wall is important to recognize, since treating the wall alone will not resolve it.
Desmoid tumors, also called aggressive fibromatosis, are uncommon fibroblastic tumors that do not metastasize but grow infiltratively into surrounding tissue and recur locally. The abdominal wall is a characteristic location. They occur most often in women of reproductive age, frequently after pregnancy or prior surgery, and are strongly associated with familial adenomatous polyposis, where they arise as part of the syndrome and can also occur in the mesentery. A firm, deep, slowly enlarging painless mass in the abdominal wall of a woman with a recent pregnancy or prior surgical scar is a classic presentation.
Soft tissue sarcomas of the abdominal wall are rare but are the diagnosis that shapes how any indeterminate solid mass is approached. Liposarcoma, undifferentiated pleomorphic sarcoma, leiomyosarcoma, and dermatofibrosarcoma protuberans can all occur here. Features raising concern include size greater than about 5 cm, location deep to the fascia, firmness, fixation, and progressive growth.
Metastatic deposits in the abdominal wall occur in patients with known cancer and occasionally as a first presentation. The Sister Mary Joseph nodule—a metastatic deposit at the umbilicus, most often from gastrointestinal, pancreatic, or ovarian primaries—is a specific and important example. Port-site metastases can develop at laparoscopic incision sites after cancer surgery. Lymphoma can also involve the abdominal wall.
Other less common entities include neurofibromas and schwannomas arising from abdominal wall nerves, elastofibroma (typically at the scapula but occasionally elsewhere), and urachal remnants and cysts in the midline below the umbilicus.
Symptoms depend on the cause. Many masses are painless and noticed incidentally by the patient or on imaging performed for another reason. Pain that changes with movement or worsens when the abdominal muscles are tensed suggests an abdominal wall origin rather than an intra-abdominal one—a distinction that matters, because abdominal wall pain is a well-recognized and frequently overlooked cause of chronic abdominal pain, with patients sometimes undergoing extensive investigation of the abdominal organs before the wall itself is considered.
Features that raise concern and warrant prompt evaluation include a mass larger than about 5 cm, one that is deep to the fascia, one that is hard or fixed to surrounding tissue, one that is progressively enlarging, one associated with unintended weight loss or other systemic symptoms, and any new mass in a patient with a history of cancer.
Diagnosis proceeds from examination to imaging and, where needed, to biopsy.
Physical examination establishes size, consistency, mobility, tenderness, relationship to scars, whether the mass reduces, and whether it lies within the wall using the muscle-tensing maneuver described above.
Ultrasound is usually the first imaging test. It is quick, involves no radiation, and readily determines whether a lesion is cystic or solid, which layer it occupies, whether it contains flowing blood on Doppler, and whether it moves or changes with straining. It reliably diagnoses many benign lesions outright—simple cysts, typical lipomas, seromas—and it identifies hernias dynamically.
CT of the abdomen and pelvis defines the mass in relation to muscle and fascia, identifies any extension into or origin from within the abdomen, detects features such as fat density in lipomatous lesions or acute blood in a hematoma, and surveys the rest of the abdomen for related findings such as a primary tumor or an intra-abdominal abscess.
MRI provides the most detailed soft tissue characterization and is the preferred test when a solid mass is indeterminate, when desmoid tumor or sarcoma is suspected, and for scar endometriosis. It defines the extent of infiltration and the relationship to surrounding structures, which is essential for surgical planning.
Image-guided core needle biopsy is used when imaging leaves a solid mass indeterminate or when a specific tissue diagnosis will change management. An important principle applies when sarcoma is a possibility: biopsy should be planned in consultation with the team that would perform any definitive surgery, so that the biopsy track can be positioned to be removed with the specimen. An unplanned excision of an unrecognized sarcoma complicates subsequent treatment considerably, which is why indeterminate deep masses larger than about 5 cm are referred before excision rather than after.
Blood tests do not diagnose an abdominal wall mass but may show anemia with significant hematoma, raised inflammatory markers with infection, and abnormalities relevant to the underlying condition.
Important to Know
Because abdominal wall mass is a finding rather than a diagnosis, the central principle is characterization before treatment. Removing a lump without understanding what it is can turn a straightforward situation into a complicated one, particularly where sarcoma or desmoid tumor is involved. Care is typically coordinated by primary care clinicians and general surgeons, with sarcoma specialists, gynecologists, dermatologists, and oncologists involved depending on the cause.
Reassurance is the appropriate outcome for most patients. Small, superficial, soft, mobile lesions with typical benign features on ultrasound—simple cysts, small lipomas, seromas, and post-surgical scar tissue—generally require no treatment. Excision is reasonable for symptomatic lesions, for cosmetic reasons, or where the diagnosis remains uncertain, but is not necessary simply because a lump exists.
Rectus sheath hematoma is usually managed conservatively. Treatment involves rest, analgesia, and careful review of anticoagulant and antiplatelet therapy in consultation with the prescribing clinician, since the decision to hold or reverse anticoagulation must weigh the reason it was prescribed. Most resolve over weeks, with the mass gradually softening and bruising migrating. Larger hematomas with ongoing bleeding, expanding size, hemodynamic instability, or significant hemoglobin drop may require transfusion, transcatheter arterial embolization, or surgery. Recurrence risk is reduced by treating the precipitating cough or strain and by reassessing the anticoagulation regimen.
Abdominal wall endometriosis is treated primarily with wide surgical excision including a margin of surrounding tissue, since incomplete removal leads to recurrence. Larger lesions may require mesh reconstruction of the resulting fascial defect. Hormonal therapy can reduce symptoms but rarely eliminates the lesion and is generally used adjunctively or when surgery is deferred. The most valuable intervention is often earlier recognition, since the diagnosis is frequently delayed for years while the mass is treated as something else.
Desmoid tumor management has shifted substantially. Because a meaningful proportion of desmoids stabilize or regress spontaneously, and because surgery carries high local recurrence rates and can be morbid in the abdominal wall, active surveillance with serial imaging is now the recommended initial approach for most patients rather than immediate resection. Treatment is reserved for progressive, symptomatic, or threatening disease and may include systemic therapy—tyrosine kinase inhibitors, low-dose chemotherapy, hormonal agents, and newer gamma-secretase inhibitors—along with radiotherapy or surgery in selected cases. Patients with desmoid tumors should be evaluated for familial adenomatous polyposis, since the association is strong and has implications for the patient and their family.
Suspected sarcoma requires referral to a specialist sarcoma centre before any attempt at excision. Management typically involves MRI, planned core biopsy, multidisciplinary review, wide excision with appropriate margins, abdominal wall reconstruction, and radiotherapy in many cases. Outcomes are meaningfully better when this sequence is followed from the start, which is why the threshold for referral of a deep or large indeterminate mass is deliberately low.
Metastatic deposits are managed within the overall oncologic plan rather than as isolated lesions. A new abdominal wall nodule in a patient with a cancer history warrants prompt evaluation, and a Sister Mary Joseph nodule in a patient without a known cancer requires a search for the primary tumor.
Abdominal wall pain without a discrete mass is worth recognizing as a related and commonly missed entity. Anterior cutaneous nerve entrapment syndrome, in which a nerve becomes entrapped as it passes through the rectus sheath, produces localized, reproducible tenderness that increases with muscle tensing and often responds to targeted local anesthetic injection. Recognizing it can spare patients repeated investigation of the abdominal organs.
Follow-up depends entirely on the diagnosis. Benign lesions confirmed on imaging generally need no surveillance, with advice to return if the lesion grows or changes. Indeterminate lesions may be followed with short-interval imaging. Desmoid tumors under active surveillance require a defined imaging schedule. Sarcomas and metastatic disease follow oncologic protocols.
Care is typically coordinated by primary care and general surgery, with sarcoma services, gynecology, dermatology, interventional radiology, and oncology involved as needed. Imaging and clinical findings are interpreted alongside the patient’s symptoms, examination, surgical and cancer history, medication list, and broader clinical context rather than in isolation.
Patient education plays an important role. Understanding that most abdominal wall lumps are benign, that imaging is used to characterize rather than because something is presumed to be serious, why a biopsy might be planned in a specific way, why some tumors are watched rather than removed, and which changes warrant prompt reassessment all contribute to appropriate care and reduce unnecessary anxiety.
Red flag symptoms include a mass that is rapidly enlarging, hard, or fixed to deeper tissue; a mass larger than about 5 cm or lying deep to the muscle layer; a new mass in someone with a history of cancer; sudden severe abdominal pain with a tender swelling, particularly in someone taking anticoagulants; expanding swelling with lightheadedness, pallor, rapid heart rate, or low blood pressure; fever, redness, warmth, or drainage from the mass; a mass that has become firm, tender, and irreducible with nausea, vomiting, distension, or inability to pass gas or stool; and unintended weight loss or night sweats accompanying a mass. These warrant prompt or emergency evaluation depending on severity, as they may indicate significant bleeding, infection, an incarcerated or strangulated hernia, or malignancy.